21 June 2019, Global clinical nutrition market is anticipated to witness an exponential growth in the forecast period. Clinical nutrition implies the correlation between human bodies and nutrients. Clinical nutrition is proportional to the treatment and diagnosis of diseases that affect the absorption, intake, and metabolism of dietary elements. It also stimulates health through prevention of diet-related diseases.
The factors that propel the growth of the market include growing aged population, escalating birth rate and premature births, rise in diabetes and metabolic disorders, changing dietary habits and lifestyle, and increasing number of malnutrition-patients. On the other hand, there are factors that may hamper the growth of the market including strict government regulations and lack of awareness among consumers regarding clinical nutrition products. Clinical nutrition market is anticipated to expand at a significant CAGR of 5.31% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Market could be explored by product type, type of disease, application, end user, and geography. Market could be explored by product type as Infant (Soy-based, Organic, Milk-based and Others), Enteral nutrition (Chronic Illness and Standard), and Parenteral nutrition. Based on the type of disease, the market could span Nutritional support in Neurological Diseases, Nutritional support in Gastrointestinal Disease, Nutritional support in Cancer, Nutritional support in Respiratory Diseases, Nutritional support in Renal Diseases, and Nutritional support in Other Diseases.
Get Sample Copy of this Report @
The key applications that could be explored in the market include Therapeutic Area (Nephrology, Gastroenterology, Oncology, Diabetes, Neurology, Critical Care, and Immunology) and Healthcare Setting (Nursing Homes, Inpatient Rehabilitation Facilities, Acute Care Hospitals, and Home Care Settings). The market could be explored based on end user as Infant and Child, Geriatrics, and Adults.
Asia-Pacific accounted for the major share of the clinical nutrition market in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include growing number of patients, high occurrence of chronic diseases, rising aged population, increasing awareness regarding enteral nutrition products, presence of established healthcare infrastructure supporting parenteral nutrition, and emerging economies. Asia-Pacific is followed by North American owing to growing aged population and increasing demand for junk food.
Some of the key players that fuel the growth of the clinical nutrition market comprise Ajinomoto Co. Inc., Abbott nutrition Inc., B. Braun Medical Inc., Baxter International Inc., Fresenius Kabi AG, Danone Baby and Medical Nutrition BV, Perrigo Company Plc, Hospira (Pfizer) Inc., Gentiva Health Services Inc., Nestle SA, and Hero Nutritional Inc. The leading companies are taking up strategies such as partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Browse Related Category Market Reports @